431 related articles for article (PubMed ID: 30904913)
21. Clinical, functional, and genetic characterization of chronic granulomatous disease in 89 Turkish patients.
Köker MY; Camcıoğlu Y; van Leeuwen K; Kılıç SŞ; Barlan I; Yılmaz M; Metin A; de Boer M; Avcılar H; Patıroğlu T; Yıldıran A; Yeğin O; Tezcan I; Sanal Ö; Roos D
J Allergy Clin Immunol; 2013 Nov; 132(5):1156-1163.e5. PubMed ID: 23910690
[TBL] [Abstract][Full Text] [Related]
22. Susceptibility to mycobacterial infections in children with X-linked chronic granulomatous disease: a review of 17 patients living in a region endemic for tuberculosis.
Lee PP; Chan KW; Jiang L; Chen T; Li C; Lee TL; Mak PH; Fok SF; Yang X; Lau YL
Pediatr Infect Dis J; 2008 Mar; 27(3):224-30. PubMed ID: 18277931
[TBL] [Abstract][Full Text] [Related]
23. [The NADPH-oxidase complex in chronic granulomatous disease: preliminary description of a cluster in Mérida-Venezuela].
Salmen S; Berrueta L; Heyworth P; Borges L; Hernández M; Muñoz J
Invest Clin; 1999 Dec; 40(4):277-300. PubMed ID: 10666954
[TBL] [Abstract][Full Text] [Related]
24. Restitution of superoxide generation in autosomal cytochrome-negative chronic granulomatous disease (A22(0) CGD)-derived B lymphocyte cell lines by transfection with p22phax cDNA.
Maly FE; Schuerer-Maly CC; Quilliam L; Cochrane CG; Newburger PE; Curnutte JT; Gifford M; Dinauer MC
J Exp Med; 1993 Dec; 178(6):2047-53. PubMed ID: 8245781
[TBL] [Abstract][Full Text] [Related]
25. NAPDH Oxidase-Specific Flow Cytometry Allows for Rapid Genetic Triage and Classification of Novel Variants in Chronic Granulomatous Disease.
Sacco KA; Smith MJ; Bahna SL; Buchbinder D; Burkhardt J; Cooper MA; Hartog NL; Kobrynski L; Patel KP; Abraham RS
J Clin Immunol; 2020 Jan; 40(1):191-202. PubMed ID: 31813112
[TBL] [Abstract][Full Text] [Related]
26. Common severe infections in chronic granulomatous disease.
Marciano BE; Spalding C; Fitzgerald A; Mann D; Brown T; Osgood S; Yockey L; Darnell DN; Barnhart L; Daub J; Boris L; Rump AP; Anderson VL; Haney C; Kuhns DB; Rosenzweig SD; Kelly C; Zelazny A; Mason T; DeRavin SS; Kang E; Gallin JI; Malech HL; Olivier KN; Uzel G; Freeman AF; Heller T; Zerbe CS; Holland SM
Clin Infect Dis; 2015 Apr; 60(8):1176-83. PubMed ID: 25537876
[TBL] [Abstract][Full Text] [Related]
27. Molecular diagnosis of X-linked chronic granulomatous disease in Iran.
Teimourian S; Rezvani Z; Badalzadeh M; Kannengiesser C; Mansouri D; Movahedi M; Zomorodian E; Parvaneh N; Mamishi S; Pourpak Z; Moin M
Int J Hematol; 2008 May; 87(4):398-404. PubMed ID: 18322777
[TBL] [Abstract][Full Text] [Related]
28. Absence of respiratory burst in X-linked chronic granulomatous disease mice leads to abnormalities in both host defense and inflammatory response to Aspergillus fumigatus.
Morgenstern DE; Gifford MA; Li LL; Doerschuk CM; Dinauer MC
J Exp Med; 1997 Jan; 185(2):207-18. PubMed ID: 9016870
[TBL] [Abstract][Full Text] [Related]
29. Incidence, severity, and prevention of infections in chronic granulomatous disease.
Mouy R; Fischer A; Vilmer E; Seger R; Griscelli C
J Pediatr; 1989 Apr; 114(4 Pt 1):555-60. PubMed ID: 2784499
[TBL] [Abstract][Full Text] [Related]
30. Impaired p47phox phosphorylation in neutrophils from patients with p67phox-deficient chronic granulomatous disease.
Belambri SA; Marzaioli V; Hurtado-Nedelec M; Pintard C; Liang S; Liu Y; Boussetta T; Gougerot-Pocidalo MA; Ye RD; Dang PM; El-Benna J
Blood; 2022 Apr; 139(16):2512-2522. PubMed ID: 35108370
[TBL] [Abstract][Full Text] [Related]
31. Chronic granulomatous disease in adults.
Liese JG; Jendrossek V; Jansson A; Petropoulou T; Kloos S; Gahr M; Belohradsky BH
Lancet; 1996 Jan; 347(8996):220-3. PubMed ID: 8551880
[TBL] [Abstract][Full Text] [Related]
32. Concomitant gene mutations of MBL and CYBB in chronic granulomatous disease: implications for host defense.
Watkins C; Saleh H; Song E; Jaishankar GB; Chi DS; Misran N; Peiris E; Altrich ML; Barklow T; Krishnaswamy G
Inflamm Allergy Drug Targets; 2012 Jun; 11(3):222-6. PubMed ID: 22280238
[TBL] [Abstract][Full Text] [Related]
33. X-linked chronic granulomatous disease: first report of mutations in patients of Argentina.
Barese C; Copelli S; Zandomeni R; Oleastro M; Zelazko M; Rivas EM
J Pediatr Hematol Oncol; 2004 Oct; 26(10):656-60. PubMed ID: 15454837
[TBL] [Abstract][Full Text] [Related]
34. Genetics and immunopathology of chronic granulomatous disease.
Stasia MJ; Li XJ
Semin Immunopathol; 2008 Jul; 30(3):209-35. PubMed ID: 18509647
[TBL] [Abstract][Full Text] [Related]
35. Chronic granulomatous disease: a 25-year patient registry based on a multistep diagnostic procedure, from the referral center for primary immunodeficiencies in Greece.
Raptaki M; Varela I; Spanou K; Tzanoudaki M; Tantou S; Liatsis M; Constantinidou N; Bakoula C; Roos D; Kanariou M
J Clin Immunol; 2013 Nov; 33(8):1302-9. PubMed ID: 24081483
[TBL] [Abstract][Full Text] [Related]
36. Inflammatory manifestations in a single-center cohort of patients with chronic granulomatous disease.
Magnani A; Brosselin P; Beauté J; de Vergnes N; Mouy R; Debré M; Suarez F; Hermine O; Lortholary O; Blanche S; Fischer A; Mahlaoui N
J Allergy Clin Immunol; 2014 Sep; 134(3):655-662.e8. PubMed ID: 24985400
[TBL] [Abstract][Full Text] [Related]
37. Clinical, functional and genetic analysis of twenty-four patients with chronic granulomatous disease - identification of eight novel mutations in CYBB and NCF2 genes.
Martel C; Mollin M; Beaumel S; Brion JP; Coutton C; Satre V; Vieville G; Callanan M; Lefebvre C; Salmon A; Pagnier A; Plantaz D; Bost-Bru C; Eitenschenck L; Durieu I; Floret D; Galambrun C; Chambost H; Michel G; Stephan JL; Hermine O; Blanche S; Blot N; Rubié H; Pouessel G; Drillon-Haus S; Conrad B; Posfay-Barbe KM; Havlicekova Z; Voskresenky-Baricic T; Jadranka K; Arriazu MC; Garcia LA; Sfaihi L; Bordigoni P; Stasia MJ
J Clin Immunol; 2012 Oct; 32(5):942-58. PubMed ID: 22562447
[TBL] [Abstract][Full Text] [Related]
38. Inheritance pattern and clinical aspects of 93 Iranian patients with chronic granulomatous disease.
Fattahi F; Badalzadeh M; Sedighipour L; Movahedi M; Fazlollahi MR; Mansouri SD; Khotaei GT; Bemanian MH; Behmanesh F; Hamidieh AA; Bazargan N; Mamishi S; Zandieh F; Chavoshzadeh Z; Mohammadzadeh I; Mahdaviani SA; Tabatabaei SA; Kalantari N; Tajik S; Maddah M; Pourpak Z; Moin M
J Clin Immunol; 2011 Oct; 31(5):792-801. PubMed ID: 21789723
[TBL] [Abstract][Full Text] [Related]
39. [Molecular aspects of chronic granulomatous disease. "the NADPH oxidase complex"].
Morel F
Bull Acad Natl Med; 2007 Feb; 191(2):377-90; discussion 390-2. PubMed ID: 17969555
[TBL] [Abstract][Full Text] [Related]
40. CRISPR-gene-engineered CYBB knock-out PLB-985 cells, a useful model to study functional impact of X-linked chronic granulomatous disease mutations: application to the G412E X91+-CGD mutation.
Beaumel S; Verbrugge L; Fieschi F; Stasia MJ
Clin Exp Immunol; 2023 Apr; 212(2):156-165. PubMed ID: 36827093
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
